Euglycemic Diabetic Ketoacidosis Precipitated by SGLT-2 Inhibitor Use, Pericarditis, and Fasting: A Case Report
Introduction: Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of diabetes mellitus. Less prevalent is euglycemic DKA (eDKA)—DKA with serum glucose less than 200 mg/dL; however, it is increasing in frequency with the introduction of sodium glucose cotransporter 2 (SGLT-2) i...
Main Authors: | Rebecca A. Mendelsohn, Anabelle N. Taveras, Benjamin A. Mazer, Lisa M. Clayton |
---|---|
Format: | Article |
Language: | English |
Published: |
eScholarship Publishing, University of California
2020-08-01
|
Series: | Clinical Practice and Cases in Emergency Medicine |
Online Access: | https://escholarship.org/uc/item/1gn8w43x |
Similar Items
-
Euglycemic diabetic ketoacidosis: The clinical concern of SGLT2 inhibitors
by: Jamila A. Benmoussa, MD, et al.
Published: (2016-12-01) -
SGLT2 Inhibitor–Induced Euglycemic Diabetic Ketoacidosis: A Case Report
by: Katherine M. Wang, et al.
Published: (2020-03-01) -
Dehydration and insulinopenia are necessary and sufficient for euglycemic ketoacidosis in SGLT2 inhibitor-treated rats
by: Rachel J. Perry, et al.
Published: (2019-02-01) -
Euglycemic Diabetic Ketoacidosis With COVID-19 Infection in Patients With Type 2 Diabetes Taking SGLT2 Inhibitors
by: Rebecca J. Vitale, MD, MPH, et al.
Published: (2021-01-01) -
A Case of SGLT2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis Following Coronary Artery Bypass Surgery
by: Deborah A. Osafehinti, MD, et al.
Published: (2021-01-01)